Katarzyna Brodowska, MD
Ophthalmology · Cleveland, OHNPI 1245642867
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $806 of the $935 with a category attached, or 86.3%. Regeneron accounts for 86.3% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for ophthalmology clinicians in OH, where the typical reported total is $1,115.
Across 4 payments — averaging $233.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$806
- Alcon$111
- Apellis Pharmaceuticals, Inc.$17
What the payments were for
- Travel & lodging$80686%
- Food & beverage$11112%
- Education$172%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $806 |
| Alcon | 1 | $111 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
How this compares
$935 in reported general payments places this provider in the 45th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $6,888 |
| Prednisolone Acetate | 41 | $1,479 |
| Ketorolac Tromethamine | 17 | $728 |
| Latanoprost | 96 | $483 |
| Brimonidine Tartrate | 55 | $451 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 40 | $347 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $224 |
| Timolol Maleate | 37 | $93 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cleveland
- Peter KaiserCleveland$1.5M
- Justis EhlersCleveland$639K
- Sunil SrivastavaCleveland$508K
- William WileyCleveland$479K
- Yasha ModiCleveland$234K
- Faruk OrgeCleveland$158K
- Danny MammoCleveland$149K
- Douglas RheeCleveland$138K
- Jeffrey GosheCleveland$82K
- William DuppsCleveland$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.